Advog 0.3 Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Voglibose (0.3mg)
Overview Advog 0.3 Tablet
Voglibose 0.3mg tablets are indicated for managing type 2 diabetes. This medication helps regulate postprandial hyperglycemia (elevated blood sugar after meals). It's prescribed when dietary modifications and other antidiabetic agents prove insufficient to maintain optimal blood glucose control. Administer Voglibose 0.3mg immediately prior to meals. Dosage and frequency are determined individually by your physician to optimize glycemic management. Discontinuing this medication abruptly is discouraged; consult your doctor first. Sudden cessation may elevate blood sugar, potentially leading to serious complications, including nephropathy and retinopathy. This medication forms part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported adverse effects include increased flatus, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your healthcare provider. While Voglibose 0.3mg alone doesn't induce hypoglycemia, concomitant use with other antidiabetic therapies (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your physician of any pre-existing hepatic or renal impairment before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should consult their physician prior to use. Always disclose all medications you are currently taking to ensure medication safety. Limit alcohol consumption while using this medicine due to the potential for increased hypoglycemia risk.
Primary Ingredients of Advog 0.3 Tablet
No text was provided. Please provide the text you would like me to rephrase.
Uses of Advog 0.3 Tablet
Managing Type 2 Diabetes
Major Benefits of Advog 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Advog tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Advog 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Advog 0.3 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Advog 0.3 Tablet on an empty stomach.
How Advog 0.3 Tablet works:
Glucovance 0.3mg tablets are used to manage diabetes. They function by blocking intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating post-prandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Advog 0.3 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Advog 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Advog 0.3 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Advog 0.3 Tablet.
KidneyCAUTION
Patients with severe renal impairment should use Advog 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with advanced liver impairment should exercise caution when using Advog 0.3 Tablets. Dosage modification for Advog 0.3 Tablets may be necessary. Physician consultation is advised.
What if you forget to take Advog 0.3 Tablet :
Omit any missed dose of Advog 0.3 Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Advog 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |






